LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 12.88 | 84.90 | 921 | 531 | 1.7345 | 1.4629 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 12.88 | 84.90 | 13 | 531 | 0.0245 | -0.5081 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 12.88 | 84.90 | 1053 | 531 | 1.9831 | 1.5909 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 14.58 | 84.90 | 20 | 663 | 0.0301 | -0.3858 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 14.58 | 84.90 | 1039 | 663 | 1.5662 | 1.3266 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 14.58 | 84.90 | 28 | 663 | 0.0422 | -0.3120 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 14.58 | 84.90 | 1106 | 663 | 1.6672 | 1.3761 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 16.29 | 84.90 | 29 | 766 | 0.0378 | -0.2870 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 16.29 | 84.90 | 1057 | 766 | 1.3784 | 1.2127 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 16.29 | 84.90 | 35 | 766 | 0.0456 | -0.2435 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 16.29 | 84.90 | 1163 | 766 | 1.5166 | 1.2803 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 17.99 | 84.90 | 31 | 898 | 0.0345 | -0.2562 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 17.99 | 84.90 | 1141 | 898 | 1.2692 | 1.1451 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 17.99 | 84.90 | 48 | 898 | 0.0534 | -0.1542 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 17.99 | 84.90 | 1274 | 898 | 1.4172 | 1.2157 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 19.69 | 84.90 | 31 | 1239 | 0.0250 | -0.2293 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 19.69 | 84.90 | 1212 | 1239 | 0.9779 | 0.9885 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 19.69 | 84.90 | 57 | 1239 | 0.0460 | -0.0979 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 19.69 | 84.90 | 1345 | 1239 | 1.0852 | 1.0427 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 21.40 | 84.90 | 36 | 1454 | 0.0247 | -0.1889 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 21.40 | 84.90 | 1249 | 1454 | 0.8586 | 0.9270 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 21.40 | 84.90 | 86 | 1454 | 0.0591 | 0.0032 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 21.40 | 84.90 | 1378 | 1454 | 0.9473 | 0.9738 | MN20160318_Q02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 23.10 | 84.90 | 43 | 1616 | 0.0266 | -0.1479 | MN20160318_Q02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 23.10 | 84.90 | 1257 | 1616 | 0.7777 | 0.8852 | MN20160318_Q02 | E22 |